On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

MLC1

modulator of VRAC current 1

The MLC1 gene provides instructions for making a protein that is predominantly found in the brain, where it plays a role in the function of astroglial cells and may be involved in fluid transport and cell adhesion. The MLC1 gene, also known as modulator of VRAC current 1, is essential for normal brain development and function.

Chromosome 22q13.33 Various HGNC:17082 Tier C
MLC1 22q13.33 p arm q arm 22

MLC1 is located on the long (q) arm of chromosome 22, at band 22q13.33. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 22 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The MLC1 gene (modulator of VRAC current 1) encodes a protein primarily located in the brain, specifically within astroglial cells. Astroglial cells are a type of glial cell that supports and maintains nerve cells. The MLC1 protein is also found in the spleen and white blood cells.

While its precise molecular role is still being researched, the MLC1 protein is thought to be involved in various crucial processes including regulating fluid flow into cells, facilitating cell adhesion, and potentially transporting molecules across the blood-brain barrier and the brain-cerebrospinal fluid barrier. These barriers are vital for protecting the brain's delicate nerve tissue.

What the gene does

The MLC1 protein functions at the junctions connecting neighbouring astroglial cells in the brain. Although its exact mechanism at these junctions is not fully understood, research indicates it may be involved in controlling fluid movement into cells and influencing the strength of cell-to-cell attachment. This suggests a role in maintaining cellular hydration and tissue integrity within the central nervous system.

Additionally, the MLC1 protein may contribute to the transport of specific molecules across key protective barriers of the brain, such as the blood-brain barrier and the brain-cerebrospinal fluid barrier. These barriers selectively control which substances can enter the brain, protecting it from harmful agents. Defects in MLC1 function can lead to impaired brain development and neurological conditions, notably Megalencephalic Leukoencephalopathy with Subcortical Cysts.

Video: Genetics 101

Chromosome location

The MLC1 gene is situated on chromosome 22, specifically at position 22q13.33. This location refers to the long (q) arm of chromosome 22, in region 13 and band 33. The MLC1 gene comprises coding regions that direct the synthesis of a protein made up of 377 amino acids.

Protein structure

The MLC1 protein consists of 377 amino acids. Structural analysis reveals a Disordered region spanning amino acids 1-36 at the N-terminus of the protein. The full functional implications of this specific domain architecture are subjects of ongoing research.

Key variants

Variants within the MLC1 gene can alter the protein's structure and function, leading to impaired cellular processes in the brain. Over 80 different types of pathogenic variants have been identified in the MLC1 gene. These genetic changes can range from single amino acid substitutions to larger deletions or insertions, impacting the protein's ability to perform its essential roles in astroglial cells.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for MLC1.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.135del
Deletion
p.Cys46fs Pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1
c.177+1del
Deletion
- Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1
c.359C>T
single nucleotide variant
p.Ala120Val Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts
c.423+1G>T
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1
c.597+1G>A
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts
c.736del
Deletion
p.Ser246fs Pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1
c.772-1G>C
single nucleotide variant
- Pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1
c.849del
Deletion
p.Ile283_Met284insTer Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1
c.881C>T
single nucleotide variant
p.Pro294Leu Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts
c.894+1G>A
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Megalencephalic leukoencephalopathy with subcortical cysts 1

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the MLC1 gene are primarily associated with Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC). This is an inherited condition that affects brain development and function. Type 1 MLC, which accounts for approximately 75% of all cases, is caused by MLC1 gene mutations. Individuals with MLC may experience problems with movement, developmental delays, and recurrent seizures due to impaired brain function.

UK clinical status

The MLC1 gene is included in several NHS England Genomic Medicine Service clinical panels, reflecting its established role in inherited conditions. It is classified as 'green' on the DDG2P, Early onset or syndromic epilepsy, Inherited white matter disorders, Intellectual disability, and White matter disorders and cerebral calcification - childhood onset panels. It is also listed on the Foetal anomalies panel (R21), indicating its significance in prenatal diagnosis and management.

Frequently asked questions

What is the main function of the MLC1 gene?

The MLC1 gene provides instructions for a protein predominantly found in astroglial cells in the brain. It is thought to be involved in regulating fluid flow into cells, cell adhesion, and transporting molecules across the brain's protective barriers.

What condition is associated with MLC1 gene variants?

Pathogenic variants in the MLC1 gene are primarily associated with Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC). This condition affects brain development and function, leading to movement problems and seizures.

How common are MLC1 gene variants in Megalencephalic Leukoencephalopathy?

MLC1 gene variants are a significant cause of Megalencephalic Leukoencephalopathy with Subcortical Cysts. More than 80 different variants have been identified, with MLC1-related changes accounting for about 75% of all Type 1 MLC cases.

References

  1. Capdevila-Nortes X, López-Hernández T, Apaja PM. Insights into MLC pathogenesis: GlialCAM is an MLC1 chaperone required for proper activation of volume-regulated anion currents. Human molecular genetics. 2013. PMID: 23793458
  2. López-Hernández T, Sirisi S, Capdevila-Nortes X. Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Human molecular genetics. 2011. PMID: 21624973
  3. Montagna G, Teijido O, Eymard-Pierre E. Vacuolating megalencephalic leukoencephalopathy with subcortical cysts: functional studies of novel variants in MLC1. Human mutation. 2006. PMID: 16470554
  4. Ilja Boor PK, de Groot K, Mejaski-Bosnjak V. Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1. Human mutation. 2006. PMID: 16652334
  5. Boor PK, de Groot K, Waisfisz Q. MLC1: a novel protein in distal astroglial processes. Journal of neuropathology and experimental neurology. 2005. PMID: 15892299
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .